Xinjian Yang Selected Research

PVB protocol

1/2022

Atorvastatin for unruptured intracranial vertebrobasilar dissecting aneurysm (ATREAT-VBD): protocol for a randomised, double-blind, blank-controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xinjian Yang Research Topics

Disease

57	Aneurysm (Aneurysms) 07/2022 - 01/2007
37	Intracranial Aneurysm (Cerebral Aneurysm) 02/2022 - 01/2007
22	Neoplasms (Cancer) 06/2022 - 06/2012
10	Aortic Dissection 10/2022 - 03/2009
9	Rupture 02/2022 - 10/2007
6	Hypoxia (Hypoxemia) 01/2021 - 03/2016
5	Thrombosis (Thrombus) 12/2021 - 03/2010
4	Arteriovenous Malformations (Arteriovenous Malformation) 02/2022 - 04/2012
4	Inflammation (Inflammations) 01/2022 - 10/2014
4	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2018 - 09/2015
3	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2019
3	Ischemic Stroke 12/2021 - 01/2021
3	Cognitive Dysfunction 08/2017 - 07/2015
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 02/2022 - 03/2014
2	Breast Neoplasms (Breast Cancer) 02/2022 - 01/2019
2	Necrosis 01/2022 - 12/2020
2	Hemorrhage 12/2021 - 07/2016
2	Pathologic Constriction (Stenosis) 01/2020 - 01/2014
2	Wounds and Injuries (Trauma) 02/2019 - 01/2019
2	Pain (Aches) 01/2019 - 02/2008
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 10/2015 - 07/2015
2	Alzheimer Disease (Alzheimer's Disease) 01/2013 - 04/2012
2	Atopic Dermatitis (Atopic Eczema) 07/2010 - 01/2009
2	Hepatitis 07/2010 - 01/2009
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Transient Ischemic Attack 12/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 12/2020
1	Atherosclerosis 12/2020
1	Starvation 08/2020
1	Hypoglycemia (Reactive Hypoglycemia) 02/2020
1	Tuberous Sclerosis (Bourneville's Disease) 01/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 02/2019
1	Wound Infection (Wound Infections) 02/2019
1	Hyperthermia 02/2019
1	Body Weight (Weight, Body) 01/2019

Drug/Important Bio-Agent (IBA)

8	Pharmaceutical PreparationsIBA 02/2022 - 01/2009
7	Therapeutic UsesIBA 06/2022 - 07/2013
5	MicroRNAs (MicroRNA)IBA 01/2018 - 09/2014
4	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2022 - 10/2007
4	ElementsIBA 02/2022 - 10/2013
3	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2022 - 12/2012
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 12/2018
3	Proteins (Proteins, Gene)FDA Link 06/2021 - 01/2014
3	MetalsIBA 10/2020 - 01/2015
3	Biomarkers (Surrogate Marker)IBA 05/2018 - 09/2014
2	Catalytic DNA (Deoxyribozyme)IBA 02/2022 - 11/2018
2	AntigensIBA 01/2022 - 01/2017
2	C-Reactive ProteinIBA 01/2022 - 12/2020
2	InterleukinsIBA 01/2022 - 12/2020
2	Atorvastatin (Lipitor)FDA Link 01/2022 - 12/2020
2	Glucose (Dextrose)FDA LinkGeneric 08/2020 - 02/2020
2	Biological ProductsIBA 08/2020 - 01/2009
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 06/2020 - 01/2018
2	SurvivinIBA 06/2020 - 11/2018
2	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2020 - 01/2019
2	Contrast MediaIBA 12/2019 - 08/2011
2	Anti-Bacterial Agents (Antibiotics)IBA 02/2019 - 11/2017
2	Messenger RNA (mRNA)IBA 12/2018 - 11/2018
2	Silicon Dioxide (Silica)FDA LinkGeneric 11/2018 - 10/2015
2	NitroreductasesIBA 09/2018 - 05/2018
2	Fluorescent Dyes (Fluorescent Probes)IBA 09/2018 - 05/2018
2	Photosensitizing Agents (Photosensitizers)IBA 01/2018 - 07/2012
2	Metal-Organic FrameworksIBA 01/2018 - 01/2017
2	Amyloid (Amyloid Fibrils)IBA 08/2017 - 01/2013
2	baicalinIBA 07/2010 - 01/2009
1	Coloring Agents (Dyes)IBA 07/2022
1	HydrogenIBA 06/2022
1	Hydroxyl RadicalIBA 06/2022
1	AntioxidantsIBA 06/2022
1	APTIBA 02/2022
1	AcidsIBA 02/2022
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 02/2022
1	VaccinesIBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	HydrogelsIBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2020
1	Glucose OxidaseIBA 08/2020
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 08/2020
1	PalladiumIBA 08/2020
1	gluconic acid (gluconate)FDA LinkGeneric 08/2020
1	ProdrugsIBA 08/2020
1	PorphyrinsIBA 02/2019
1	PolymersIBA 02/2019
1	Zoledronic Acid (Zometa)FDA Link 01/2019
1	Nanoparticle Drug Delivery SystemIBA 01/2019
1	Amino Acids FDA Link 01/2019

Therapy/Procedure

50	Stents 10/2022 - 11/2009
24	Therapeutics 02/2022 - 10/2010
7	Drug Therapy (Chemotherapy) 02/2022 - 05/2018
7	Aftercare (After-Treatment) 01/2022 - 11/2013
5	Retreatment 01/2021 - 01/2014
4	Endovascular Procedures 03/2015 - 04/2012
3	Immunotherapy 06/2022 - 01/2017
3	Photochemotherapy (Photodynamic Therapy) 06/2020 - 07/2012
2	Radiotherapy 01/2021 - 11/2018
2	Catheters 01/2019 - 08/2011
1	PVB protocol 01/2022
1	Phototherapy (Light Therapy) 02/2019
1	Photothermal Therapy 01/2019